As diabetes becomes increasingly intertwined with modern lifestyles, a new generation of nutraceutical products is attempting to bridge traditional botanical knowledge with contemporary nutritional science
New Delhi:
For millions of Indians, diabetes has quietly become part of everyday life. The morning blood-sugar check, the tablet after breakfast, the occasional HbA1c test and the constant calculation of what can—and cannot—be eaten have become routine for many families.
Yet diabetes management is changing.
The conversation is gradually moving beyond simply lowering blood glucose to a broader focus on metabolic health, insulin sensitivity, nutrition, physical activity, weight management and sustainable lifestyle change.
The World Health Organization estimates that the global number of people living with diabetes rose from around 200 million in 1990 to 830 million in 2022. The organisation also emphasises that diabetes management involves a combination of healthy eating, physical activity, blood-glucose monitoring, medication where necessary and regular screening for complications.
Against this backdrop, India’s rapidly expanding nutraceutical sector is exploring ways to combine the country’s long history of botanical medicine with modern nutritional science.
One of the products entering this space is MetaMist, a nutraceutical oral spray from Glynostic a brand owned by Jivakriti Bio-Sciences Private Limited , positioned around daily metabolic and blood-sugar support.
Not Just Another Herbal Product
India has never been short of traditional remedies.
What is changing is the way consumers want these ingredients delivered and understood.
Today’s health-conscious consumer increasingly asks questions about ingredients, standardisation, evidence, formulation and convenience. This has created space for nutraceutical products that attempt to bring together botanical ingredients with contemporary formulation approaches.
MetaMist represents this emerging category.
According to Glynostic, its formulation combines Berberine, Gudmar (Gymnema), Cinnamon, Fenugreek, Jamun Seed and Chromium, with the product positioned as nutritional support for healthy glucose metabolism and everyday metabolic wellness. The company also states that its formulation is non-GMO and third-party lab tested.
The distinction is important.
The proposition is not simply to take an age-old herb and put it into a modern package. Instead, the broader nutraceutical approach attempts to bring traditional botanical knowledge into a framework that today’s consumers recognise—one built around specific bioactive compounds, nutritional ingredients and convenient delivery formats.
Berberine at the Centre of the Conversation
Among the ingredients attracting the greatest scientific interest is berberine, a naturally occurring plant compound that has been investigated for its potential role in glucose and lipid metabolism.
A 2024 systematic review and meta-analysis published in Frontiers in Pharmacology analysed 50 studies involving 4,150 participants. Researchers reported improvements in several glucose and lipid measures with berberine, including fasting blood glucose and post-meal glucose; when used alongside glucose-lowering medication, the analysis also found reductions in HbA1c. The authors, however, noted the need for further research into mechanisms, safety and treatment combinations.
This growing body of research has helped push berberine from a relatively niche botanical compound into the mainstream metabolic-health conversation.
MetaMist incorporates berberine alongside other botanical and micronutrient ingredients rather than relying on a single active ingredient. Glynostic describes the formulation as being designed to support healthy glucose balance, insulin response, carbohydrate metabolism and overall metabolic wellness.
The Rise of the Multi-Ingredient Approach
Diabetes is a complex metabolic condition. Diet, physical activity, body weight, insulin sensitivity and other health factors can all influence glucose management.
That is why the emerging nutraceutical conversation increasingly focuses on combinations rather than isolated ingredients.
Gymnema, traditionally known as Gudmar, has a long history of use in Indian traditional medicine. Fenugreek, cinnamon and Jamun seed are also familiar ingredients in traditional approaches to metabolic wellness, while chromium is an essential micronutrient involved in normal carbohydrate metabolism.
The idea behind combining such ingredients is to create a broader nutritional-support platform rather than positioning one ingredient as a universal solution.
That philosophy also mirrors the larger shift in diabetes management itself.
WHO recommends regular physical activity and healthy eating as important components of type 2 diabetes management, with medication used when clinically necessary.
Why an Oral Spray?
There is another element to MetaMist that reflects changing consumer behaviour: its delivery format.
The oral spray is designed to make supplementation easy to incorporate into a daily routine. For consumers accustomed to tablets and capsules, the format represents a different approach to nutritional supplementation.
Glynostic positions the spray as a convenient daily product intended to complement healthier lifestyle habits rather than replace prescribed medical treatment.
The distinction is particularly relevant in diabetes.
A nutraceutical should not be viewed as a substitute for medicines prescribed by a physician, particularly for people whose glucose levels require pharmacological treatment.
From Diabetes Control to Metabolic Health
Perhaps the most significant change is philosophical.
For years, diabetes conversations often centred almost exclusively on one number: blood sugar.
The newer metabolic-health approach looks at the larger picture.
What does a person’s diet look like?
How active are they?
Are they carrying excess weight?
How consistent is their sleep?
Are they monitoring their glucose?
Are they following their prescribed treatment?
And, importantly, can healthier habits be maintained for years rather than weeks?
WHO notes that healthy diets and physical activity can help prevent or delay type 2 diabetes and are important components of ongoing management.
This is the environment in which products such as MetaMist are emerging.
Can Nutraceuticals Contribute to Diabetes Reversal?
The word “reversal” requires some qualification.
Type 2 diabetes can, in some individuals, enter remission following substantial and sustained improvements in weight and metabolic health. However, remission is not synonymous with a permanent cure, and individual outcomes vary.
There is also an important difference between evidence for an individual ingredient and evidence for a finished product.
Research on berberine, for example, provides scientific interest in its potential metabolic effects. But those findings should not automatically be interpreted as proof that every berberine-containing formulation—or MetaMist specifically—can reverse diabetes.
For a product such as MetaMist, the more appropriate role is as part of a broader lifestyle and nutritional strategy, alongside appropriate medical supervision.
A New Opportunity for India’s Nutraceutical Industry
India’s traditional healthcare heritage gives its nutraceutical industry a unique starting point.
The opportunity now lies in translating that heritage into products that meet modern expectations around formulation, convenience, quality and scientific evaluation.
Glynostic’s MetaMist is an example of this transition: a product combining familiar Indian botanical ingredients with a modern nutraceutical positioning and an oral-spray delivery system.
Its significance may therefore extend beyond one product.
It reflects a wider change in consumer thinking—from waiting for metabolic problems to worsen to actively looking for ways to support healthier daily habits.
The Road Ahead
Diabetes management is unlikely to have a single solution.
For most people, sustainable outcomes will continue to depend on a combination of appropriate medical care, nutrition, physical activity, monitoring and behavioural change.
Nutraceuticals may have a role within that ecosystem, particularly as consumers seek more convenient and nutrition-oriented approaches to supporting metabolic health.
MetaMist represents one such attempt to bring together traditional botanical knowledge and modern nutraceutical thinking.
Whether this new generation of products can ultimately transform diabetes care will depend not simply on marketing, but on continued scientific research, responsible formulation and high-quality clinical evidence.
For now, however, the direction of the industry is clear: the future of metabolic wellness is increasingly moving toward prevention, personalised nutrition, lifestyle intervention and evidence-informed nutritional support.
And in a country facing an enormous diabetes burden, that shift could prove to be one of the most important developments in the health and wellness industry.
